6,640 Shares in HCA Healthcare, Inc. $HCA Bought by Sandro Wealth Management LLC

Key Points

• Sandro Wealth Management LLC opened a new position in HCA Healthcare (NYSE:HCA), acquiring 6,640 shares worth about $3.1 million — roughly 2.6% of the firm's portfolio and its 9th-largest holding.
• HCA reported Q EPS of $7.15 (vs. $7.19 expected) and revenue of $19.11B (up 4.3% y/y), and set FY2026 guidance of 29.10–31.50 EPS versus analysts' consensus of about 30.05.
• The company declared a quarterly dividend of $0.78 per share (annualized $3.12), yielding ~0.7%, with an ex-dividend date of June 16 and payment on June 30.

Sandro Wealth Management LLC bought a new position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund bought 6,640 shares of the company's stock, valued at approximately $3,100,000. HCA Healthcare comprises approximately 2.6% of Sandro Wealth Management LLC's investment portfolio, making the stock its 9th biggest position.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in HCA. Brighton Jones LLC acquired a new stake in HCA Healthcare during the 4th quarter worth $1,021,000. NewEdge Advisors LLC boosted its stake in HCA Healthcare by 11.9% during the 1st quarter. NewEdge Advisors LLC now owns 3,859 shares of the company's stock worth $1,334,000 after purchasing an additional 409 shares during the last quarter. Sivia Capital Partners LLC boosted its stake in HCA Healthcare by 5.5% during the 2nd quarter. Sivia Capital Partners LLC now owns 630 shares of the company's stock worth $241,000 after purchasing an additional 33 shares during the last quarter. Jump Financial LLC acquired a new position in shares of HCA Healthcare during the 2nd quarter valued at about $2,073,000. Finally, Sei Investments Co. boosted its position in shares of HCA Healthcare by 56.3% during the 2nd quarter. Sei Investments Co. now owns 136,589 shares of the company's stock valued at $52,328,000 after acquiring an additional 49,214 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company's stock.

HCA Healthcare Price Performance

Shares of NYSE:HCA opened at $433.73 on Friday. The firm has a market capitalization of $96.50 billion, a PE ratio of 14.92, a price-to-earnings-growth ratio of 1.38 and a beta of 1.19. The firm's 50-day moving average is $497.66 and its two-hundred day moving average is $485.41. HCA Healthcare, Inc. has a 1 year low of $330.00 and a 1 year high of $556.52.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings results on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.19 by ($0.04). The business had revenue of $19.11 billion for the quarter, compared to analysts' expectations of $19.09 billion. HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The firm's revenue for the quarter was up 4.3% on a year-over-year basis. During the same quarter last year, the company earned $6.45 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Analysts expect that HCA Healthcare, Inc. will post 30.05 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th will be paid a dividend of $0.78 per share. The ex-dividend date is Tuesday, June 16th. This represents a $3.12 dividend on an annualized basis and a yield of 0.7%. HCA Healthcare's dividend payout ratio is 10.73%.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on the stock. Cantor Fitzgerald reissued an "overweight" rating on shares of HCA Healthcare in a research report on Wednesday, March 4th. Deutsche Bank Aktiengesellschaft lowered their price target on shares of HCA Healthcare from $558.00 to $540.00 and set a "buy" rating on the stock in a research report on Tuesday. Leerink Partners lowered their price target on shares of HCA Healthcare from $573.00 to $500.00 and set an "outperform" rating on the stock in a research report on Monday, April 27th. Argus upped their target price on shares of HCA Healthcare from $530.00 to $560.00 and gave the company a "buy" rating in a research report on Friday, February 6th. Finally, Weiss Ratings reaffirmed a "buy (b)" rating on shares of HCA Healthcare in a research report on Friday, March 27th. Sixteen research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $520.55.

Insider Activity

In related news, SVP Christopher F. Wyatt sold 4,000 shares of the company's stock in a transaction that occurred on Wednesday, February 11th. The shares were sold at an average price of $505.00, for a total transaction of $2,020,000.00. Following the sale, the senior vice president directly owned 44,379 shares in the company, valued at approximately $22,411,395. This represents a 8.27% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Michael S. Cuffe sold 1,500 shares of the company's stock in a transaction that occurred on Tuesday, February 3rd. The stock was sold at an average price of $498.09, for a total transaction of $747,135.00. Following the sale, the executive vice president owned 30,003 shares in the company, valued at $14,944,194.27. The trade was a 4.76% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 15,214 shares of company stock valued at $7,797,595 over the last three months. 1.50% of the stock is currently owned by corporate insiders.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.